Express Scripts Holding Company (ESRX) Issues Q4 Earnings Guidance
Express Scripts Holding Company (NASDAQ:ESRX) issued an update on its fourth quarter earnings guidance on Tuesday morning. The company provided EPS guidance of $2.03-2.11 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.04.
Express Scripts Holding Company (NASDAQ:ESRX) traded up 0.34% during mid-day trading on Tuesday, reaching $58.85. The company had a trading volume of 3,836,752 shares. Express Scripts Holding Company has a 12-month low of $55.80 and a 12-month high of $77.50. The stock has a 50-day moving average of $61.26 and a 200 day moving average of $62.06. The company has a market capitalization of $33.99 billion, a price-to-earnings ratio of 10.21 and a beta of 0.88.
Express Scripts Holding (NASDAQ:ESRX) last released its earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $1.90. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The business had revenue of $24.68 billion during the quarter, compared to the consensus estimate of $25.68 billion. During the same period last year, the business posted $1.74 earnings per share. The business’s revenue for the quarter was down 2.9% on a year-over-year basis. On average, analysts expect that Express Scripts Holding Company will post $6.99 EPS for the current year.
A number of analysts have issued reports on ESRX shares. Jefferies Group LLC set a $72.00 target price on Express Scripts Holding and gave the stock a buy rating in a research report on Tuesday, August 29th. BidaskClub downgraded Express Scripts Holding from a hold rating to a sell rating in a research report on Wednesday, July 12th. Royal Bank Of Canada started coverage on Express Scripts Holding in a research report on Tuesday, September 19th. They issued a sector perform rating and a $68.00 target price for the company. UBS AG downgraded Express Scripts Holding from a market perform rating to an underperform rating in a research report on Monday, October 9th. Finally, Raymond James Financial, Inc. reissued an underperform rating on shares of Express Scripts Holding in a research report on Monday, October 9th. Seven equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating, six have given a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of Hold and a consensus price target of $69.09.
In other news, Director Woodrow A. Myers, Jr. sold 3,900 shares of Express Scripts Holding stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $63.93, for a total value of $249,327.00. Following the transaction, the director now owns 11,500 shares in the company, valued at $735,195. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, VP Phyllis S. Anderson sold 578 shares of Express Scripts Holding stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $63.13, for a total value of $36,489.14. Following the completion of the transaction, the vice president now owns 10,530 shares in the company, valued at approximately $664,758.90. The disclosure for this sale can be found here. Insiders have sold 5,641 shares of company stock worth $357,317 in the last 90 days. Company insiders own 0.68% of the company’s stock.
WARNING: “Express Scripts Holding Company (ESRX) Issues Q4 Earnings Guidance” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/10/24/express-scripts-holding-company-esrx-issues-q4-earnings-guidance.html.
Express Scripts Holding Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.